Client’s Testimonial:
“Thank you so much for the excellent case you built for the I-140. You were meticulous and I am really pleased with your services. I have already recommended you to a couple of my friends yesterday.”
On February 16th, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Research Scientist in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: Postdoctoral Research Scientist
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: New York
Processing Time: 5 days (Premium Processing requested)
Case Summary:
“In summary, [Client] has made significant contributions to the fields of biomedical engineering and stem cell tissue engineering throughout his career. He shows an extraordinary level of knowledge and skills that far surpasses his peers. His presence in the United States not only constitutes an invaluable asset to the fields of biomedical engineering and stem cell engineering, but also substantially benefits our country in its global competitiveness in science and technology.”
This impactful statement is one of many made by specialists in our client’s field of biomedical engineering. These professionals volunteered testimonials to champion our client’s EB-1A (Alien of Extraordinary Ability) petition. The legal team at North America Immigration Law Group (WeGreened.com) helped our client to incorporate these testimonials into the petition dossier that we submitted to the USCIS on his behalf. Our client, a postdoctoral research scientist from India, chose to file his case under Premium Processing, which allowed for rapid adjudication; it only took the USCIS five days to approve his EB-1A petition.
We thoroughly demonstrated the value of our client’s work to the United States by documenting the 346 citations collected from his 8 publications, and the 10 times he judged the work of other biomedical engineers. We proved that his development of methods for the production of potent nanoparticles, the safe and efficient reprogramming of cells, and the engineering of skeletal muscle cells and cardiac tissues laid the groundwork for advancing the United States’ application of improved methods for drug delivery, cell and tissue engineering, and artificial organ development.
We congratulate our client on the approval of his EB-1A petition and wish him the best in his future investigations.